| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 236.11B | 228.57B | 221.50B | 215.71B | 209.44B |
| Gross Profit | 86.97B | 81.99B | 79.73B | 78.99B | 74.33B |
| EBITDA | 84.05B | 87.80B | 86.98B | 86.90B | 84.69B |
| Net Income | 38.70B | 37.19B | 36.96B | 36.36B | 35.62B |
Balance Sheet | |||||
| Total Assets | 536.35B | 534.30B | 523.74B | 523.00B | 512.88B |
| Cash, Cash Equivalents and Short-Term Investments | 57.34B | 57.94B | 52.40B | 53.00B | 43.28B |
| Total Debt | 38.02B | 43.23B | 43.64B | 43.47B | 38.91B |
| Total Liabilities | 135.42B | 138.49B | 131.02B | 131.47B | 123.75B |
| Stockholders Equity | 386.39B | 382.83B | 380.29B | 379.12B | 377.38B |
Cash Flow | |||||
| Free Cash Flow | 49.60B | 50.25B | 43.58B | 42.52B | 39.27B |
| Operating Cash Flow | 77.50B | 79.24B | 74.56B | 75.95B | 74.86B |
| Investing Cash Flow | -28.20B | -35.33B | -50.17B | -30.79B | -31.17B |
| Financing Cash Flow | -48.46B | -41.52B | -40.73B | -34.80B | -34.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $32.44B | 26.19 | 10.15% | 3.15% | 5.74% | 7.12% | |
77 Outperform | $17.83B | 16.17 | 15.56% | 6.14% | -5.21% | -7.45% | |
70 Outperform | $24.87B | 17.32 | 9.03% | 5.03% | -3.16% | 4.70% | |
62 Neutral | $72.34B | 14.48 | 17.05% | 2.69% | 1.14% | 83.48% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | $33.34B | 7.35 | -8.37% | 3.77% | 19.67% | -278.51% |